Aseptika Releases SENSOR I App: The Clinical Version of Activ8rlives on Apple’s App Store
The SENSOR suite of Apps was designed and trialled in collaboration an NHS Trust in a clinical trial funded by NHS England, which has just been successfully completed in Hampshire, through the highly acclaimed Small Business Research Initiative (SBRI) Healthcare programme.
The App was designed for use by people of any age, but is especially inclusive for older patients. The colourful user interface, the step-by-step instructions and motivational messages enable the user to collect 40 vital signs and questions about their daily health, all in less than 10 minutes a day.
The volunteer patients daily measured, without supervision: lung function by simple spirometry, blood oxygen saturation, blood pressure, heart rate, levels of physical activity and body composition, alongside a number of questions capturing the data routinely requested in paper-based questionnaires, which are generally only undertaken at the start, middle and end of research studies. The response of volunteers (average age 67) on the clinical trial has been highly positive. The SENSOR I App collects and displays the data on that day for the key vital signs and displays these to the user but the user is “blinded” to the longitudinal data – useful in clinical research studies. These data are simultaneously uploaded to Activ8rlives’ UK-based web-servers for review as a cohort by clinical teams through a dedicated clinician portal in Activ8rlives.
The ownership of the data is retained by the user at all times, but can be shared (by permission of the user) with the ecosystem of care workers, supporters and family who are involved in their care. The SENSOR II App will be released shortly in which users in future randomised controlled trials are unblinded to their longitudinal data, which is displayed as charts and bar charts as they record their vital signs on a daily basis to enable them to self-monitor and self-manage their respiratory disease at home and to watch for signs of impending ill health associated with respiratory exacerbations. Kevin Auton Ph.D, Managing Director of Aseptika commented: “The release of the SENSOR I App via the Apple Store is an important milestone for Aseptika. It supports the increasing use of self-monitoring at home by the patient as policy makers shift the balance of care from hospitals to the home and the community throughout the EU. The SENSOR App suite are tools which can be used to facilitate a new partnership between the patient and their clinical teams and complement the new Activ8rlives v3.0 App, which shares many of the same features as SENSOR but is designed for use by the consumer.”
SENSOR I and the Activ8rlives 3.0 Apps are free to download. There is no charge to the patient for the use of Activ8rlives to securely and confidentially store their data. The decision to share data with clinical teams remains at the sole discretion of the user.
- Ends –
For more information on Aseptika Ltd, Activ8rlives and products, please visit: www.Activ8rlives.com
Activ8rlives, Activ8rlives.com, BuddyWOTCH and EyKos are trademarks of Aseptika Ltd. For press information, please contact:
Jessica Auton
Marketing Director
Direct +44 (0)1480 352 821
Mobile +44 (0)7455 922 122